2019\u5e747\u67089\u65e5<\/p>\n
³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e<\/p>\n
<\/p>\n
³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 \u5d07\u3001\u4ee5\u4e0b \u300c³Ô¹Ï±¬ÁÏ\u300d)\u306f\u3001\u6709\u5bb3\u4e8b\u8c61\u3092\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u306b\u7ba1\u7406\u3067\u304d\u308b\u6700\u65b0\u306e\u30af\u30e9\u30a6\u30c9\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u3001³Ô¹Ï±¬ÁÏ Vault Safety<\/a><\/strong>\u3092\u63d0\u4f9b\u958b\u59cb\u3057\u305f\u3053\u3068\u3092\u767a\u8868\u3057\u307e\u3057\u305f\u3002\u3053\u308c\u307e\u3067\u306bApellis Pharmaceuticals\u793e\u304a\u3088\u3073Catalyst Clinical Research\u793e\u3092\u306f\u3058\u3081\u3068\u3059\u308b4\u793e\u306e\u30a2\u30fc\u30ea\u30fc\u30a2\u30c0\u30d7\u30bf\u30fc\u304c\u3001Vault Safety\u306e\u5c0e\u5165\u3092\u65e2\u306b\u6c7a\u5b9a\u3057\u3066\u3044\u307e\u3059\u3002(\u672c\u30ea\u30ea\u30fc\u30b9\u306f\u3001³Ô¹Ï±¬ÁÏ\u7c73\u56fd\u672c\u793e\u304c\u767a\u8868\u3057\u305f\u5831\u9053\u8cc7\u6599\u306e\u6284\u8a33\u3067\u3059\u3002\u539f\u6587\u306f\u3053\u3061\u3089<\/a><\/strong>\u304b\u3089\u304a\u8aad\u307f\u3044\u305f\u3060\u3051\u307e\u3059\u3002)<\/p>\n <\/p>\n Catalyst Clinical Research\u793e\u306eCMO\u3067\u3042\u308bLisa Hornick\u6c0f\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u30b3\u30e1\u30f3\u30c8\u3057\u3066\u3044\u307e\u3059\u3002\u300c\u898f\u5236\u5909\u66f4\u306e\u5ea6\u306b\u5b89\u5168\u6027\u60c5\u5831\u7ba1\u7406\u30b7\u30b9\u30c6\u30e0\u3092\u66f4\u65b0\u3057\u7d9a\u3051\u308b\u306e\u306f\u5927\u304d\u306a\u8ca0\u62c5\u3067\u3059\u3002³Ô¹Ï±¬ÁÏ Vault Safety\u306f\u3001\u6700\u65b0\u306e\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3067\u5b89\u5168\u6027\u7ba1\u7406\u306e\u8ca0\u62c5\u3092\u8efd\u6e1b\u3057\u3066\u304f\u308c\u308b\u305f\u3081\u3001\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u306e\u5411\u4e0a\u3068\u3068\u3082\u306b\u3001\u30d1\u30fc\u30c8\u30ca\u30fc\u3068\u306e\u9023\u643a\u3092\u5f37\u5316\u3059\u308b\u3053\u3068\u304c\u3067\u304d\u307e\u3059\u3002\u300d<\/p>\n Vault Safety\u306f\u3001\u533b\u85ac\u54c1\u306e\u5b89\u5168\u6027\u7ba1\u7406\u3084\u76e3\u8996\u3092\u884c\u3046\u7d44\u7e54\u304c\u3001\u4e16\u754c\u4e2d\u306e\u5f53\u5c40\u306b\u3088\u308b\u898f\u5236\u5909\u66f4\u306b\u3044\u3061\u65e9\u304f\u5bfe\u5fdc\u3067\u304d\u308b\u3088\u3046\u3001\u7d99\u7d9a\u7684\u306a\u30a4\u30ce\u30d9\u30fc\u30b7\u30e7\u30f3\u3092\u901a\u3058\u3066\u30b5\u30dd\u30fc\u30c8\u3057\u3001\u30b3\u30b9\u30c8\u3068\u6642\u9593\u306e\u304b\u304b\u308b\u65e7\u5f0f\u306e\u30aa\u30f3\u30d7\u30ec\u30df\u30b9\u5b89\u5168\u6027\u7ba1\u7406\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3092\u30a2\u30c3\u30d7\u30b0\u30ec\u30fc\u30c9\u3059\u308b\u4f5c\u696d\u3092\u6392\u9664\u3057\u307e\u3059\u3002\u307e\u305f\u3001\u30ea\u30a2\u30eb\u30bf\u30a4\u30e0\u306e\u30ec\u30dd\u30fc\u30c8\u4f5c\u6210\u6a5f\u80fd\u3068\u53cc\u65b9\u5411\u30c0\u30c3\u30b7\u30e5\u30dc\u30fc\u30c9\u306b\u3088\u308a\u3001\u5404\u75c7\u4f8b\u306e\u30b9\u30c6\u30fc\u30bf\u30b9\u3092\u5b8c\u5168\u306b\u53ef\u8996\u5316\u3057\u307e\u3059\u3002\u3055\u3089\u306b\u3001\u9023\u643a\u3084\u7d71\u5408\u304c\u7c21\u7565\u5316\u3055\u308c\u308b\u305f\u3081\u3001\u7d44\u7e54\u306e\u5185\u5916\u3092\u554f\u308f\u305a\u3001\u3042\u3089\u3086\u308b\u95a2\u4fc2\u8005\u306e\u9593\u3067\u30c7\u30fc\u30bf\u3092\u30b7\u30fc\u30e0\u30ec\u30b9\u306b\u5171\u6709\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002\u305d\u306e\u7d50\u679c\u3001\u30b9\u30dd\u30f3\u30b5\u30fc\u3001CRO\u3001\u304a\u3088\u3073\u30d1\u30fc\u30c8\u30ca\u30fc\u9593\u3067\u306e\u696d\u52d9\u52b9\u7387\u3068\u30b3\u30f3\u30d7\u30e9\u30a4\u30a2\u30f3\u30b9\u3082\u5411\u4e0a\u3057\u307e\u3059\u3002<\/p>\n ³Ô¹Ï±¬ÁÏ Vault Safety\u306e\u30b7\u30cb\u30a2\u30f4\u30a1\u30a4\u30b9\u30d7\u30ec\u30b8\u30c7\u30f3\u30c8\u517c\u30bc\u30cd\u30e9\u30eb\u30de\u30cd\u30fc\u30b8\u30e3\u30fc\u3067\u3042\u308bBrian Longo\u306f\u3001\u6b21\u306e\u3088\u3046\u306b\u8ff0\u3079\u3066\u3044\u307e\u3059\u3002\u300c\u5f93\u6765\u3001\u5b89\u5168\u6027\u7ba1\u7406\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u306f\u975e\u5e38\u306b\u9ad8\u4fa1\u3067\u3001\u65b0\u8208\u306e\u88fd\u85ac\u4f01\u696d\u3084\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u4f01\u696d\u306b\u3068\u3063\u3066\u306f\u5c0e\u5165\u3057\u3065\u3089\u3044\u3082\u306e\u3067\u3057\u305f\u3002³Ô¹Ï±¬ÁÏ Vault Safety\u306a\u3089\u3001\u30af\u30e9\u30a6\u30c9\u3092\u5229\u7528\u3059\u308b\u3053\u3068\u3067\u3053\u306e\u3088\u3046\u306a\u969c\u58c1\u3092\u306a\u304f\u3059\u3053\u3068\u304c\u3067\u304d\u3001\u3042\u3089\u3086\u308b\u898f\u6a21\u306e\u4f01\u696d\u304c\u5b89\u5168\u6027\u7ba1\u7406\u30bd\u30ea\u30e5\u30fc\u30b7\u30e7\u30f3\u3092\u6301\u3061\u3001\u81ea\u8eab\u3067\u30b3\u30f3\u30c8\u30ed\u30fc\u30eb\u3067\u304d\u308b\u3088\u3046\u306b\u306a\u308a\u307e\u3059\u3002\u300d<\/p>\n Vault Safety\u306f\u3001\u3042\u3089\u3086\u308b\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u3068\u7d99\u7d9a\u7684\u306a\u30d3\u30b8\u30cd\u30b9\u696d\u52d9\u306b\u5bfe\u5fdc\u3057\u305f\u30af\u30e9\u30a6\u30c9\u30b5\u30fc\u30d3\u30b9\u3067\u3059\u3002³Ô¹Ï±¬ÁÏ \u306f\u3001³Ô¹Ï±¬ÁÏ Development Cloud<\/a><\/strong>\u306e\u4e00\u90e8\u3068\u3057\u3066\u3001Vault Clinical<\/a><\/strong>\u3001Vault Quality<\/a><\/strong>\u3001\u304a\u3088\u3073Vault RIM<\/a><\/strong>\u3068\u3068\u3082\u306b\u3001\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u696d\u754c\u306b\u304a\u3051\u308b\u533b\u85ac\u54c1\u306e\u958b\u767a\u3092\u52a0\u901f\u3055\u305b\u308b\u305f\u3081\u306e\u6975\u3081\u3066\u5305\u62ec\u7684\u306a\u7d71\u5408\u30af\u30e9\u30a6\u30c9\u30a2\u30d7\u30ea\u30b1\u30fc\u30b7\u30e7\u30f3\u30b9\u30a4\u30fc\u30c8\u3092\u63d0\u4f9b\u3057\u307e\u3059\u3002\u8a73\u7d30\u306b\u3064\u3044\u3066\u306fveeva.com\/jp\/DevelopmentCloud<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n <\/p>\n \u3010³Ô¹Ï±¬ÁÏ Systems\u793e\u306b\u3064\u3044\u3066\u3011<\/strong> \u3010Forward-looking Statements\u3011<\/strong> 2019\u5e747\u67089\u65e5 ³Ô¹Ï±¬ÁÏ Japan\u682a\u5f0f\u4f1a\u793e ³Ô¹Ï±¬ÁÏ Systems\u3010NYSE:VEEV\u3011(\u672c\u793e : \u30ab\u30ea\u30d5\u30a9\u30eb\u30cb\u30a2\u5dde\u30d7\u30ec\u30b6\u30f3\u30c8\u30f3\u3001\u65e5\u672c\u6cd5\u4eba \u672c\u793e : \u6771\u4eac\u90fd\u6e0b\u8c37\u533a\u3001\u65e5\u672c\u6cd5\u4eba\u4ee3\u8868\u53d6\u7de0\u5f79 : \u5ca1\u6751 …<\/p>\n","protected":false},"author":131,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[322,341],"tags":[],"class_list":["post-42744","post","type-post","status-publish","format-standard","hentry","category-press-release","category-case-study"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42744"}],"collection":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/users\/131"}],"replies":[{"embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/comments?post=42744"}],"version-history":[{"count":2,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42744\/revisions"}],"predecessor-version":[{"id":42746,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/posts\/42744\/revisions\/42746"}],"wp:attachment":[{"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/media?parent=42744"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/categories?post=42744"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.veeva.com\/jp\/wp-json\/wp\/v2\/tags?post=42744"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\n³Ô¹Ï±¬ÁÏ Systems\u793e\u306f\u30b0\u30ed\u30fc\u30d0\u30eb\u306a\u30e9\u30a4\u30d5\u30b5\u30a4\u30a8\u30f3\u30b9\u4f01\u696d\u3084\u305d\u306e\u4ed6\u306e\u898f\u5236\u3092\u53d7\u3051\u308b\u88fd\u9020\u696d\u8005\u5411\u3051\u306b\u3001\u30af\u30e9\u30a6\u30c9\u30d9\u30fc\u30b9\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2\u3092\u63d0\u4f9b\u3059\u308b\u30ea\u30fc\u30c7\u30a3\u30f3\u30b0\u30ab\u30f3\u30d1\u30cb\u30fc\u3067\u3059\u3002\u4e16\u754c\u6700\u5927\u898f\u6a21\u306e\u88fd\u85ac\u4f1a\u793e\u304b\u3089\u30d0\u30a4\u30aa\u30c6\u30af\u30ce\u30ed\u30b8\u30fc\u5206\u91ce\u306e\u65b0\u8208\u4f01\u696d\u307e\u3067750\u793e\u3092\u8d85\u3048\u308b\u9867\u5ba2\u306b\u6280\u8853\u9769\u65b0\u3078\u306e\u53d6\u308a\u7d44\u307f\u3084\u5353\u8d8a\u3057\u305f\u88fd\u54c1\u529b\u306b\u3088\u3063\u3066\u3001\u304a\u5ba2\u69d8\u306e\u6210\u529f\u306b\u30b3\u30df\u30c3\u30c8\u3059\u308b\u69d8\u3005\u306a\u30b5\u30fc\u30d3\u30b9\u3092\u63d0\u4f9b\u3057\u3066\u3044\u307e\u3059\u3002³Ô¹Ï±¬ÁÏ\u306f\u3001\u30b5\u30f3\u30d5\u30e9\u30f3\u30b7\u30b9\u30b3\u306e\u30d9\u30a4\u30a8\u30ea\u30a2\u306b\u672c\u793e\u3092\u7f6e\u304d\u3001\u30e8\u30fc\u30ed\u30c3\u30d1\u3001\u30a2\u30b8\u30a2\u3001\u30e9\u30c6\u30f3\u30a2\u30e1\u30ea\u30ab\u306b\u62e0\u70b9\u3092\u5c55\u958b\u3057\u3066\u3044\u307e\u3059\u3002\u8a73\u3057\u304f\u306f\u3001\u516c\u5f0f\u30b5\u30a4\u30c8<\/a><\/strong>\u3092\u3054\u89a7\u304f\u3060\u3055\u3044\u3002<\/p>\n
\nThis release contains forward-looking statements, including the market demand for and acceptance of ³Ô¹Ï±¬ÁÏ\u2019s products and services, the results from use of ³Ô¹Ï±¬ÁÏ\u2019s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon ³Ô¹Ï±¬ÁÏ\u2019s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent ³Ô¹Ï±¬ÁÏ\u2019s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and ³Ô¹Ï±¬ÁÏ disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect ³Ô¹Ï±¬ÁÏ\u2019s financial results are included under the captions, \u201cRisk Factors\u201d and \u201cManagement\u2019s Discussion and Analysis of Financial Condition and Results of Operations,\u201d in the company\u2019s filing on Form 10-K for the period ended April 30, 2019. This is available on the company\u2019s website at www.veeva.com<\/a> under the Investors section and on the SEC\u2019s website at www.sec.gov<\/a>. Further information on potential risks that could affect actual results will be included in other filings ³Ô¹Ï±¬ÁÏ makes with the SEC from time to time.<\/p>\n","protected":false},"excerpt":{"rendered":"